Unigestion Holding SA cut its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 330,129 shares of the company’s stock after selling 4,804 shares during the period. Unigestion Holding SA’s holdings in Colgate-Palmolive were worth $24,267,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently modified their holdings of the company. Haverford Trust Co. grew its stake in shares of Colgate-Palmolive by 3.0% during the third quarter. Haverford Trust Co. now owns 47,640 shares of the company’s stock valued at $3,502,000 after buying an additional 1,401 shares during the last quarter. Daiwa Securities Group Inc. grew its stake in shares of Colgate-Palmolive by 10.3% during the third quarter. Daiwa Securities Group Inc. now owns 40,728 shares of the company’s stock valued at $2,994,000 after buying an additional 3,788 shares during the last quarter. Bartlett & Co. LLC grew its stake in shares of Colgate-Palmolive by 140.6% during the third quarter. Bartlett & Co. LLC now owns 140,368 shares of the company’s stock valued at $10,318,000 after buying an additional 82,039 shares during the last quarter. Tibra Equities Europe Ltd bought a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $1,103,000. Finally, Fulcrum Capital LLC bought a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $221,000. Institutional investors and hedge funds own 76.09% of the company’s stock.
NYSE:CL traded down $0.24 during midday trading on Friday, hitting $66.63. The stock had a trading volume of 3,488,827 shares, compared to its average volume of 3,535,505. Colgate-Palmolive has a one year low of $57.51 and a one year high of $76.41. The company has a market capitalization of $57.34 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 5.24 and a beta of 0.73. The stock has a 50-day moving average of $69.67 and a 200 day moving average of $71.59. The company has a quick ratio of 0.25, a current ratio of 1.03 and a debt-to-equity ratio of 43.94.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, November 1st. The company reported $0.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.01. Colgate-Palmolive had a return on equity of 6,492.71% and a net margin of 15.04%. The company had revenue of $3.93 billion for the quarter, compared to analysts’ expectations of $3.95 billion. During the same quarter in the prior year, the firm earned $0.72 earnings per share. Colgate-Palmolive’s revenue was up 2.2% compared to the same quarter last year. On average, sell-side analysts anticipate that Colgate-Palmolive will post 2.83 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 23rd will be issued a dividend of $0.43 per share. The ex-dividend date is Tuesday, October 22nd. This represents a $1.72 dividend on an annualized basis and a yield of 2.58%. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.
A number of research firms have recently commented on CL. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $76.00 to $71.00 and set a “neutral” rating on the stock in a research note on Monday. Wells Fargo & Co increased their price objective on Colgate-Palmolive from $68.00 to $70.00 and gave the stock a “market perform” rating in a research note on Monday, July 29th. Citigroup increased their price objective on Colgate-Palmolive from $77.00 to $79.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 20th. ValuEngine cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Monday. Finally, Bank of America dropped their price objective on Colgate-Palmolive from $82.00 to $77.00 and set a “buy” rating on the stock in a research note on Monday. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $72.57.
In other Colgate-Palmolive news, Chairman Ian M. Cook sold 17,750 shares of the company’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $68.30, for a total transaction of $1,212,325.00. Following the completion of the sale, the chairman now owns 995,075 shares in the company, valued at $67,963,622.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Philip G. Shotts sold 8,919 shares of the company’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $71.05, for a total value of $633,694.95. Following the sale, the vice president now owns 50,399 shares of the company’s stock, valued at approximately $3,580,848.95. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 193,361 shares of company stock valued at $13,722,098. 1.14% of the stock is owned by company insiders.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Recommended Story: Why are analyst ratings important in trading stocks?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.